A drug with the SMILES N#CCc1c(C#N)c(N)nc(N2CCN(S(=O)(=O)c3ccccc3F)CC2)c1C#N has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of -9.751%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
N#CCc1c(C#N)c(N)nc(N2CCN(S(=O)(=O)c3ccccc3F)CC2)c1C#N
N#CCc1c(C#N)c(N)nc(N2CCN(S(=O)(=O)c3ccccc3F)CC2)c1C#N
2-amino-4-(cyanomethyl)-6-[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]pyridine-3,5-dicarbonitrile